Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 226

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study

Open access
Doraiswamy, P. Murali, Sperling, Reisa A., Coleman, R. Edward, Johnson, Keith A., Reiman, Eric M., Davis, Mat D., Grundman, Michael, Sabbagh, Marwan N., Sadowsky, Carl H., Fleisher, Adam S., Carpenter, Alan, Clark, Christopher M., Joshi, Abhinay D., Mintun, Mark A., Skovronsky, Daniel M., Pontecorvo, Michael J., For the AV45-A11 Study Group, Duara, Ranjan, Sabbagh, Marwan, Ahern, Geoffrey Lawrence, Holub, Richard F., Farmer, Mildred V., Safirstein, Beth Emmie, Alva, Gustavo, Longmire, Crystal F., Jewell, George, Johnson, Keith A., Korn, Ron, Reiman, Eric M., Wendt, Jeanette K., Wong, Dean, Doraiswamy, P. Murali, Coleman, R. Edward, Devous, Michael, Jennings, Danna, Weiner, Michael W., Murphy, Cynthia A, Kovnat, Karel D., Williamson, Jeff D., Sadowsky, Carl H. · 2012 · Neurology

Abstract

OBJECTIVES: Florbetapir F 18 PET can image amyloid-β (Aβ) aggregates in the brains of living subjects. We prospectively evaluated the prognostic utility of detecting Aβ pathology using florbetapir PET in subjects at risk for progressive cognitive decline. METHODS: A total of 151 subjects who previously participated in a multicenter florbetapir PET imaging study were recruited for longitudinal assessment. Subjects included 51 with recently diagnosed mild cognitive impairment (MCI), 69 cognitively normal controls (CN), and 31 with clinically diagnosed Alzheimer disease dementia (AD). PET images were visually scored as positive (Aβ+) or negative (Aβ-) for pathologic levels of β-amyloid aggregation, blind to diagnostic classification. Cerebral to cerebellar standardized uptake value ratios (SUVr) were determined from the baseline PET images. Subjects were followed for 18 months to evaluate changes in cognition and diagnostic status. Analysis of covariance and correlation analyses were conducted to evaluate the association between baseline PET amyloid status and subsequent cognitive decline. RESULTS: In both MCI and CN, baseline Aβ+ scans were associated with greater clinical worsening on the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog (p < 0.01) and Clinical Dementia Rating-sum of boxes (CDR-SB) (p < 0.02). In MCI Aβ+ scans were also associated with greater decline in memory, Digit Symbol Substitution (DSS), and Mini-Mental State Examination (MMSE) (p < 0.05). In MCI, higher baseline SUVr similarly correlated with greater subsequent decline on the ADAS-Cog (p < 0.01), CDR-SB (p < 0.03), a memory measure, DSS, and MMSE (p < 0.05). Aβ+ MCI tended to convert to AD dementia at a higher rate than Aβ- subjects (p < 0.10). CONCLUSIONS: Florbetapir PET may help identify individuals at increased risk for progressive cognitive decline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e3182661f74

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 226

Metadata

Authors
Doraiswamy, P. M., Sperling, R. A., Coleman, R. E., Johnson, K. A., Reiman, E. M., Davis, M. D., Grundman, M., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., Carpenter, A., Clark, C. M., Joshi, A. D., Mintun, M. A., Skovronsky, D. M., Pontecorvo, M. J., For the AV45-A11 Study Group, Duara, R., Sabbagh, M., Ahern, G. L., Holub, R. F., Farmer, M. V., Safirstein, B. E., Alva, G., Longmire, C. F., Jewell, G., Johnson, K. A., Korn, R., Reiman, E. M., Wendt, J. K., Wong, D., Doraiswamy, P. M., Coleman, R. E., Devous, M., Jennings, D., Weiner, M. W., Murphy, C. A., Kovnat, K. D., Williamson, J. D., & Sadowsky, C. H.
Venue
Neurology
Published
2012-10-16
Volume
79
Issue
16
Pages
1636-1644
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2052300396
Cited by
226
References
11
FWCI
20.70
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study. https://app.cochat.ai/papers/10.1212/wnl.0b013e3182661f74
The paper
Doraiswamy, P. M., Sperling, R. A., Coleman, R. E., Johnson, K. A., Reiman, E. M., Davis, M. D., Grundman, M., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., Carpenter, A., Clark, C. M., Joshi, A. D., Mintun, M. A., Skovronsky, D. M., Pontecorvo, M. J., For the AV45-A11 Study Group, Duara, R., Sabbagh, M., . . . Sadowsky, C. H. (2012). Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study. Neurology. https://doi.org/10.1212/wnl.0b013e3182661f74

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.